KALV - KalVista Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Breakdown
ttm
4/30/2019
4/30/2018
4/30/2017
Total Revenue
11,792
16,127
8,394
1,504
Operating Expense
54,628
45,947
27,099
23,843
Operating Income
-42,836
-29,820
-18,705
-22,339
Net Non Operating Interest Income Expense
1,848
1,397
82
36
Other Income Expense
10,054
7,731
2,818
3,700
Pretax Income
-30,934
-20,692
-15,805
-18,603
Tax Provision
-
124
-
-
Net Income Common Stockholders
-31,058
-20,816
-15,805
-20,775
Diluted NI Available to Com Stockholders
-31,058
-20,816
-15,805
-20,775
Basic EPS
-
-0.0014
-0.0015
-0.0045
Diluted EPS
-
-0.0014
-0.0015
-0.0045
Basic Average Shares
-
15,081
10,322
4,647
Diluted Average Shares
-
15,081
10,322
4,647
Total Operating Income as Reported
-42,836
-29,820
-18,705
-22,339
Total Expenses
54,628
45,947
27,099
23,843
Net Income from Continuing & Discontinued Operation
-31,058
-20,816
-15,805
-18,603
Normalized Income
-31,269
-20,852
-14,231
-19,974
Interest Income
1,848
1,397
82
36
Net Interest Income
1,848
1,397
82
36
EBIT
-42,836
-29,820
-18,705
-22,339
EBITDA
-41,914
-
-
-
Reconciled Depreciation
922
378
180
40
Net Income from Continuing Operation Net Minority Interest
-31,058
-20,816
-15,805
-18,603
Total Unusual Items Excluding Goodwill
211
49
-1,574
1,371
Total Unusual Items
211
49
-1,574
1,371
Normalized EBITDA
-42,125
-29,491
-16,951
-23,670
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
13.23
0
0